We’re bringing the latest on COVID-19 therapeutics to quickly get treatments to our underserved neighbors.
We’ve partnered with COVID-19 response experts across the country to help you learn the latest on therapeutics, explore treatment options, and identify the right medication for your patients. Use the toolkit below and learn more.
You can also explore clinical resources to launch a Test-to-Treat program in your area. Downloadable workflows, process maps, and communication tools make it easier to launch a program, so you can focus on what’s important, saving lives.
It’s important we stay ahead of the curve.
The U.S. Department of Health & Human Services Administration for Strategic Preparedness & Response (ASPR) leads the nation’s preparedness and response to public health emergencies. Derek Eisenor, MD, Medical Officer in ASPR’s Division of Clinical Development, provides an overview of COVID-19 therapeutic options for COVID-19 patients with mild to moderate symptoms.
Learn more about oral antivirals, intravenous antivirals, and a monoclonal antibody.